Drug profile · INN
clofibrate
CLOFIBRATE
clofibrate (CLOFIBRATE) is a peroxisome proliferator-activated receptor alpha agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — clofibrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
clofibrate (CLOFIBRATE) is a peroxisome proliferator-activated receptor alpha agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Peroxisome proliferator-activated receptor alpha agonist
Primary target: Peroxisome proliferator-activated receptor alpha
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is clofibrate?
clofibrate (CLOFIBRATE) is a peroxisome proliferator-activated receptor alpha agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for clofibrate?
CLOFIBRATE is a marketed brand name for clofibrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clofibrate?
clofibrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.